Cellectis

France · 250 Employees
Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 21 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells. As part of its commitment to a cure, Cellectis remains dedicated to its goal of providing life-saving UCART product candidates to address unmet needs for multiple cancers including acute myeloid leukemia (AML), B-cell acute lymphoblastic leukemia (B-ALL), multiple myeloma (MM), Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Cellectis headquarters are in Paris, France, with additional locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more about us, visit our website: www.cellectis.com. To learn more about our community guidelines, visit: http://www.cellectis.com/en/social-media-guidelines/ Follow our other social media accounts: @cellectis on Twitter and Cellectis YouTube TALEN® is a registered trademark owned by the Cellectis Group.

概述

国家 France
成立时间 1999
总部 8 rue de la Croix Jarry, Paris, Île-de-France, FR, 75013
电话号码 +33 181691600
网站 http://www.cellectis.com
LinkedIn http://www.linkedin.com/company/cellectis
Twitter https://twitter.com/cellectis
Facebook
员工数 250
行业 research,
简介 Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer

技术

Google Analytics

Analytics and Tracking

Linkedin Marketing Solutions

Advertising Networks

Mobile Friendly

Other

Nginx

Load Balancers

Outlook

Email Providers

YouTube

Online Video Platforms

reCAPTCHA

Captcha

常见问题

Cellectis 在哪里?

Cellectis 的总部位于 8 rue de la Croix Jarry, Paris, Île-de-France, FR, 75013

Cellectis 的电话号码是多少?

Cellectis 的电话号码是 +33 181691600

Cellectis 的官方网站是什么?

Cellectis 的公司官方网站是 http://www.cellectis.com

Cellectis 是做什么的?

Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer

Cellectis 的业务有哪些?

gene editing,life sciences,oncology,tcell therapies,genome engineering,allogeneic,offtheshef cart therapies

Cellectis 的年收入是多少?

Cellectis 的收入是 25725000美元

Cellectis 有多少员工?

Cellectis 有 250 名员工

Cellectis 属于哪个行业?

Cellectis 从事以下行业: research

Cellectis 使用什么技术?

Cellectis 使用的一些流行技术包括: Google Analytics,Linkedin Marketing Solutions,Mobile Friendly,Nginx,Outlook,YouTube,reCAPTCHA

如何联系 Cellectis?

Cellectis 联系信息: 电话号码:+33 181691600, 网站:http://www.cellectis.com, 邮箱:rob***@***.com

Cellectis 的社交媒体链接是什么?

Cellectis 领英:http://www.linkedin.com/company/cellectis,fackbook:,twitte:https://twitter.com/cellectis

Cellectis 是一家上市公司吗?

是的,Cellectis是一家上市公司,在nasdaq公开挂牌上市,上市交易代码:CLLS

Cellectis 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 Cellectis?

Cellectis 有 0 家投资者,包括 。

管理层

Bob Bosley

Associate Director, Facility Management

Katie N

VP Translational Clinical Development

Andy Coffman

Senior Research Associate

Roman Minine

Comptable général Senior

Caroline Roudet

VP Clinical Program Management and Operations

员工

Andre Choulika

Chief Executive Officer

Gauthier Vittecoq

Responsable des services techniques

Ky Nam-Wortman

Executive Vice President & Chief Human Resource Officer

Isabelle Chion-Sotinel

Ingénieur d'étude Preclinique

Jordan Skinner

Research Associate

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google